Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy.
Eosinophil cationic protein (ECP) in nasal secretions was determined in 34 infants with respiratory syncytial virus (RSV) bronchiolitis during the acute infection stage and one and six months later. ECP in serum was determined in 19 of these children at the same time. Myeloperoxidase (MPO) was determined in the same 19 children at the acute infection stage and after one month. All children were followed prospectively for two years after the infection with regard to the development of bronchial obstructive symptoms. Asthma, defined as three or more episodes of bronchial obstruction verified by a physician, developed in 18% of children and less severe obstructive symptoms in 29%. A screening test for food IgE antibodies in serum was performed six months and a skin prick test two years after the acute infection. Nasal ECP/albumin ratios after six months were significantly higher than during the acute RSV infection. MPO, but not ECP, levels in serum were significantly elevated at the time of acute infection compared with levels after one month. Nasal ECP/albumin ratios at the acute infection were compared to a control group of 27 infants with non-RSV upper respiratory tract infections and did not differ. It was not possible to predict, either from ECP/albumin ratios in nasal secretion or from ECP and MPO in serum, which children would develop asthma, other bronchial obstructive symptoms or positive IgE tests.
Sigurs
N
N
Department of Paediatrics, Borås Central Hospital, Sweden.
Bjarnason
R
R
Sigurbergsson
F
F
D000208:Acute Disease; D001249:Asthma / Q000175:diagnosis / Q000821:virology*; D001798:Blood Proteins / Q000378:metabolism*; D001988:Bronchiolitis / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000821:virology; D016022:Case-Control Studies; D047091:Eosinophil Granule Proteins; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000821:virology*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D017817:Nasal Lavage Fluid / Q000737:chemistry*; D009195:Peroxidase / Q000097:blood*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D018357:Respiratory Syncytial Virus Infections / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D012260:Ribonucleases
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D009195:Peroxidase; D012260:Ribonucleases